Entity

Time filter

Source Type

Redwood City, CA, United States

Patent
Facet Biotech | Date: 2010-09-28

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.


The use of CD56bright NK cell counts and IL-2 receptor protein expression as predictive biomarkers for the efficacy of anti-IL-2R antibody treatment in patients diagnosed with multiple sclerosis.


The use of CD56bright NK cell counts as a biomarker for the efficacy of anti-IL-2R antibody treatment in patients diagnosed with multiple sclerosis.


Patent
Facet Biotech | Date: 2010-06-08

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Discover hidden collaborations